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This controlled study was performed to test the hypothesis that the prophylactic single dose of
either dexmedetomidine or fentanyl reduces the incidence of emergence agitation post sevoﬂurane
anesthesia in children.
Patients and methods: Ninety pediatric patients were scheduled for elective surgical procedures
under general anesthesia and caudal block. They were randomized to one of three groups (each
one is 30 patients); fentanyl group (1 lg/kg), dexmedetomidine (DEX) group (0.15 lg/kg), and con-
trol group. Recovery was assessed by time until eye opening on command, pain was evaluated by
the children’s and infants’ postoperative pain scale (CHIPPS) and adequacy of recovery was
assessed using a Modiﬁed Aldert score. Both were recorded every 15 min. Behavior score was
recorded in the pre- and postoperative periods.
Main results: Patients in control group obtained higher values (9.65 ± 0.34) in the modiﬁed Aldert
score than patients who received fentanyl (9.58 ± 0.30) and dexmedetomidine (9.37 ± 0.37). There
was signiﬁcant difference between dexmedetomidine and fentanyl groups For pain assessment,
patients in control group suffered from pain when measured by CHIPPS (0.93 ± 0.56) more than
patients in dexmedetomidine group (0.48 ± 0.45) and fentanyl group (0.13 ± 0.35), with more sig-
niﬁcant pain in dexmedetomidine group when compared to fentanyl group (p< 0.05). As regard868767.
.com (O.M. Asaad).
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32 O.M. Asaad et al.behavior during emergence, there were signiﬁcant differences between the placebo with 40% agita-
tion and both fentanyl group with 21.4% agitation (p= 0.002) and dexmedetomidine group with
16.7% agitation (p= 0.001), while there were no signiﬁcant differences between fentanyl and dex-
medetomidine group.
Conclusions: Incidence of postoperative agitation in pediatric patients receiving sevoﬂurane was
decreased from 40% with placebo to 16.7% with dexmedetomidine and 21.4% with fentanyl with
no signiﬁcant differences between dexmedetomidine and fentanyl groups.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Sevoﬂurane is used frequently in pediatric patients, when inha-
lational induction of anesthesia is required, because of its fast
and non-irritating effects on the airway. The speed of emer-
gence from sevoﬂurane anesthesia, however, sometimes pre-
sents a dilemma to both patient and anesthetist. Sevoﬂurane
in particular has been associated with an increased amount
of agitation on emergence from anesthesia in children when
compared with a more soluble anesthetic (halothane) even in
the absence of any surgical intervention [1,2]. However, the ex-
act etiology of restlessness after sevoﬂurane anesthesia is still
not known [3]. Postoperative pain is regarded as a contributing
factor, but the phenomenon is also present when there is ade-
quate pain control [4]. Concern about pain, the presence of
strangers or rapid return to consciousness in an unfamiliar
environment might provoke post anesthetic agitation in chil-
dren [5].
The use of analgesics or sedatives has been proposed for the
management of these restless post anesthetic states. However,
the side effects of these drugs, including respiratory depression,
are potentially harmful and lead to an increased length of stay
in the postanesthesia care unit (PACU), resulting in patient
discomfort and increased perioperative costs [6].
In children, emergence delirium may mimic pain, separa-
tion anxiety and/or hunger. The lack of consistent deﬁnition
and difﬁculty with reproducing results may make comparisons
of different studies difﬁcult [1].
Dexmedetomidine has a relatively high ratio of a2/a1 activ-
ity (1620:1 as compared with 220/1 for clonidine), and there-
fore, is considered a full agonist of the a2 receptor. This may
result in more potent effects of sedation without unwanted car-
diovascular effects from a1 receptor activation. The 2-h half-
life of dexmedetomidine is nearly fourfold shorter than that
of clonidine, which increases the likelihood that a continuous
infusion of dexmedetomidine might be useful for sedation [7].
This controlled study was performed to test the hypothesis
that the prophylactic use of either dexmedetomidine or fenta-
nyl reduces the incidence of emergence agitation after sevoﬂu-
rane based anesthesia in children.2. Patients and methods
2.1. Patient population
This controlled randomized study was done after approval of
institutional ethics committee and obtaining an informed writ-
ten consent from parents. The study was conducted at Abu El
Rish Pediatric Hospital from October 2007 to November 2008.
It was designed to include ninety pediatric patients, aged5–10 years, with physical status ASA I. All surgical procedures
were elective of an expected duration of 30–60 min, e.g. ingui-
nal hernia repair, hydrocele, or circumcision under general
anesthesia and caudal block to relief pain. All operations were
performed in supine position. Exclusion criteria include
chronic or acute intake of any sedative and analgesic drug,
any known adverse effect to the study drugs, and failure of
the caudal block.
2.2. Methods
2.2.1. Anesthesia technique and study design
After history tacking and clinical examination, the following
laboratory testswere ordered and reviewedpreoperatively; com-
plete blood picture, kidney function tests (urea and creatinine),
liver function tests (SGOT, SGPT, albumin and bilirubin) and
bleeding proﬁle (PT, PTT and INR). Solid foodwas not allowed
6 h before surgery but clear ﬂuids were given for up to 4 h preop-
eratively. No premedication was given to the patients. Before
induction of anesthesia routine monitoring was applied which
include pre-cordial stethoscope, noninvasive automatic blood
pressure, pulse oximeter and electrocardiograph. Body core
temperature was measured by oropharyngeal temperature
probe and maintained between 36 and 37 C using heated mat-
tress and warmed intravenous ﬂuids.
Induction of anesthesia was with 50% nitrous oxide and
sevoﬂurane up to 8% in oxygen with total gas ﬂow P5 L/
min. After loss of consciousness, a peripheral arm vein was
cannulated for drug and ﬂuid administration. The trachea
was intubated using an appropriately-sized uncuffed endotra-
cheal tube when patients were in a sufﬁciently deep level of
anesthesia. Intubation was performed without the use of mus-
cle relaxants. A gas module (Drager/Vamos) for measurement
of end-expiratory concentration of sevoﬂurane and end-tidal
carbon dioxide tension was applied after intubation.
At this point, patients were randomly assigned by a con-
cealed envelope method into one of three groups (each group
is 30 patients); fentanyl group, received 1 lg/kg fentanyl, dex-
medetomidine (DEX) group (Precedex, Abbott Laboratories
Inc., Abbott Park, IL) (supplied in 2-ml ampoules at a concen-
tration of 100 mg/ml) received 0.15 lg/kg. The calculated dose
of fentanyl and dexmedetomidine for each patient was pre-
pared in a total volume of 10 ml normal saline and was infused
over a period of 10 min. The 3rd group is control group, re-
ceived saline 10 ml over 10 min. All syringes with dexmede-
tomidine, fentanyl or placebo were prepared by the same
investigator. Administration of anesthesia and the study drugs
and perioperative data collection were done by two investiga-
tors blinded to the study drugs.
After endotracheal intubation, patients were breathing
spontaneously via a Jackson-Rees modiﬁcation of the Ayre’s
Table 2 Modiﬁed Aldert score.
Score
Activity 2 Able to move four extremities
1 Able to move two extremities
0 Not able to move any extremities
Respiration 2 Able to breathe deeply and cough
1 Limited respiratory eﬀort
(dyspnea)
0 No spontaneous respiratory
eﬀort
Circulation 2 Systolic ABP ±20% of
preanesthetic level
1 Systolic ABP ±20% to 50% of
preanesthetic level
0 Systolic ABP ±51% or more of
preanesthetic level
Consciousness 2 Full alertness seen in patient’s
ability to answer questions
1 Aroused when called by name
0 Failure to elicit a response upon
auditory stimulation
SPO2
(% on room air)
2 >94%
1 90–94%
0 <90%
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studied drugs on respiratory function (respiratory rate and
end-tidal CO2). No muscle relaxants were used throughout
the operative procedure. Sevoﬂurane then reduced to 3% in
50% nitrous oxide, and caudal block with (0.25% bupiva-
caine) 0.5 ml/kg was been performed in all patients. Then the
concentration of sevoﬂurane set at 1% end-tidal in 50% ni-
trous oxide until the end of surgery. Failure of caudal block
was been deﬁned as any increase in heart rate (HR) and/or
mean arterial blood pressure (MAP) >10% than the preinci-
sion value. Patients received an infusion of Ringer’s solution
in 5% dextrose, given a rate of 6 ml/kg/h. At the end of sur-
gery, sevoﬂurane was discontinued and the trachea was extu-
bated, and time to eye opening was calculated (deﬁned as
time from the end of anesthesia to eye opening on command).
2.2.2. Postoperative recovery and assessment
Patients were transferred to the recovery room for further
observation. Pain was evaluated by the children’s and infants’
postoperative pain scale (CHIPPS) (Table 1) and adequacy of
recovery was assessed using a Modiﬁed Aldert score (Table 2).
Behavior during both pre- and postoperative periods was rated
on a four-point scale: 1 = calm; 2 = not calm but could be eas-
ily calmed; 3 = not easily calmed, moderately agitated or rest-
less; 4 = combative, excited or disoriented. For purposes of
analysis, grades 1and 2 in the scale of behavior were consid-
ered no agitation and grades 3 and 4 were considered presence
of agitation.
2.2.3. Data collection
HR and MAP were recorded at the following periods: Before
induction of anesthesia (baseline), after administration of
study drugs (every 5 min intraoperatively) and = every
15 min in the PACU. Respiratory rate (RR) and end-tidal
CO2 (EtCO2) were recorded after induction and just prior to
administration of study drugs and every 5 min
intraoperatively.
 Recovery was assessed by time until eye opening on
command.
 Modiﬁed Aldert score and CHIPPS score were recorded
every 15 min.
 Behavior score was recorded in the pre- and postoperative
periods.
2.2.4. Statistical analysis
Data were statistically described in terms of range,
mean ± standard deviation (±SD), frequencies (number ofTable 1 Children’s and infants’ postoperative pain scale [8].
Categories 0 1
Facial
expression
No particular expression
or smile
Oc
wit
Position of
the legs
Normal position or
relaxed
Un
Position of
the trunk
Lying quietly or normal
position moves easily
Sq
for
Crying No cry Mo
comcases) and relative frequencies (percentages) when appropriate.
Comparison of quantitative variables between the study
groups was done using one way AVOVA for independent sam-
ples in comparing three groups when normally distributed and
Kruskal Wallis for independent samples when not normally
distributed. For comparing categorical data, Chi square (v2)
test was performed. Exact test was used instead when the ex-
pected frequency is less than 5. A probability value (p value)
less than 0.05 was considered statistically signiﬁcant. All statis-
tical calculations were done using computer programs Micro-
soft Excel 2007 (Microsoft Corporation, NY, USA) and
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) version 15 for Microsoft Windows. Sample
size calculation was done using Behavior score as it was con-
sidered to be the principal study outcome. According to previ-
ous studies, the expected responses of agitation in control was
set at 47 – 60% while that of fentanyl was 13 – 15 % and for
dexmetomidine was 10 – 17 %. If the true difference in the
experimental and control proportions is 30 – 45, we will need
to study around 20 to 36 subjects per group to be able to reject
the null hypothesis that the population means of the experi-
mental and control groups are equal with 80% power. Type2
casional grimace or frown,
hdrawn, disinterested
Frequent to constant frown,
quivering chin, clenched jaw
easy, restless, tense Kicking or legs drawn up
uirming, shifting back and
th, tense
Arched, rigid, or jerking
ans or whimpers, occasional
plaint
Crying steadily, screams or sobs,
frequent complaint
Table 3 Demographic data of patients in all groups (mean ± SD and ratio for sex).
Control group DEX group Fentanyl group
(n= 30) (n= 30) (n= 30)
Age (years) 6.6 ± 1.32 6.07 ± 1.4 6.84 ± 1.7
Gender (M/F) 28/2 27/3 27/3
Body weight (kg) 21.3 ± 2.7 19.9 ± 3.5 21.67 ± 3.7
Duration of anesthesia (min) 60.14 ± 4.29 62.45 ± 4.13 60.25 ± 4.22
Duration of surgery (min) 47.3 ± 4.96 42.61 ± 5.30 45.05 ± 4.22
Table 4 Hemodynamic data of patients in all groups (means ± SD).
Control group DEX group Fentanyl group
(n= 30) (n= 30) (n= 28)
Pre-operative HR 105.3 ± 13.27 109.03 ± 15.87 102.73 ± 10.96
MAP 72.8 ± 5.32 73.43 ± 5.2 72.1 ± 5.7
Intra-operative HR 97.66 ± 8.24 89.69 ± 6.4#, * 94.5 ± 8.1+
MAP 68.64 ± 3.1 68.26 ± 4.4 64.86 ± 4.7#,+
RR 26.9 ± 4.1 26.02 ± 4.29 23.98 ± 3.46
ETCO2 36.7 ± 3.04 36.93 ± 2.8 35.66 ± 2.18
Post-operative HR 101.48 ± 6.5 98.04 ± 12.04 99.7 ± 6.74
MAP 75.5 ± 4.44 74.82 ± 5.57 72.05 ± 5.28
* p< 0.05 control vs. dexmedetomidine groups.
+ p< 0.05 control vs. fentanyl groups.
# p< 0.05 fentanyl vs. dexmedetomidine groups.
Table 5 Time (min) to eyes opening and to discharge from post-anesthesia care unit.
Control group DEX group Fentanyl group
(n= 30) (n= 30) (n= 28)
Time to eye opening 8.27 ± 1.41 9.20 ± 1.6* 8.79 ± 2.149
Time to shift to ward 17.6 ± 2.37 19.53 ± 6.569 18.07 ± 6.104
* p< 0.05 control vs. dexmedetomidine groups.
34 O.M. Asaad et al.I error probability associated with this test of this null hypoth-
esis is 0.05. The case: control ratio was set at 1. Calculations
were done using PS Power and Sample Size Calculations soft-
ware, version 2.1.30 for MSWindows (William D. Dupont and
Walton D. Vanderbilt, USA).
3. Results
Ninety patients were recruited for this study (thirty in each of
the study group). Two patients were excluded in the fentanyl
group because of failure of caudal block (as there was increase
in HR and MAP >10% than the pre-incision value). All
groups were comparable as regards demographic criteria
(age, gender and body weight) as well as duration of anesthesia
and duration of surgery (Table 3). Also, the results of all lab-
oratory tests were within normal and comparable in all groups.
HR decreased signiﬁcantly, intraoperatively, in both dex-
medetomidine and fentanyl groups in comparison to control
group (p< 0.05), and it showed more signiﬁcant decrease
in dexmedetomidine when compared to fentanyl group
(p< 0.05). In the postoperative period HR increased in all
groups in comparison to intraoperative values but there were
no signiﬁcant differences between them (p> 0.05). Also,
MAP decreased in all groups during the procedures but its
decrease was more in fentanyl group than dexmedetomidineand control groups (p< 0.05) and no signiﬁcant differences
between dexmedetomidine and control group. In the postop-
erative period the MAP increased in all groups, the differ-
ences between the three groups were insigniﬁcant.
Respiratory rate (RR) and end-tidal carbon dioxide (ETCO2)
were comparable in all groups of the study intraoperatively
(p> 0.05) (Table 4).
Time to eye opening was greater in the dexmedetomidine
group compared to the fentanyl and control groups, with sig-
niﬁcant differences between dexmedetomidine and control
groups (p< 0.05). The difference between fentanyl group
and the other two groups were statistically insigniﬁcant
(p> 0.05) (Table 5). Time to discharge from post-anesthesia
care unit (PACU) in the dexmedetomidine group was slightly
greater than that in the fentanyl and control groups but the
differences between the three groups were statistically insignif-
icant (p> 0.05) (Table 5).
Adequacy of recovery was assessed using a modiﬁed Aldert
score, and pain was assessed with the children’s and infants’
postoperative pain scale (CHIPPS). Both were evaluated by
the anesthetist in the recovery room. Patients in control group
recovered from anesthesia faster and obtained higher values
(9.65 ± 0.34) in the modiﬁed Aldert score than patients who
received fentanyl (9.58 ± 0.30) and dexmedetomidine
(9.37 ± 0.37). There were signiﬁcant differences between con-
Figure 1 Modiﬁed Aldert score in all groups of the study.
*p< 0.05 control vs. dexmedetomidine groups. +p< 0.05 control
vs. fentanyl groups. #p< 0.05 fentanyl vs. dexmedetomidine
groups.
Figure 2 CHIPPS score in all groups of the study. *p< 0.05
control vs. dexmedetomidine groups. +p< 0.05 control vs.
fentanyl groups. #p< 0.05 fentanyl vs. dexmedetomidine groups.
Table 6 Behavior score-postoperative.
Control Fentanyl DEX
(n= 30) (n= 28) (n= 30)
Behavior-post
Score 1 Count 9 21 25
% Within group 30.0 75.0 83.3
Score 2 Count 9 1 0
% Within group 30.0 3.6 0.0
Score 3 Count 7 6 5
% Within group 23.3 21.4 16.7
Score 4 Count 5 0 0
% Within group 16.7 0.0 0.0
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idine and fentanyl groups, with no signiﬁcant differences be-
tween fentanyl and control groups (Fig. 1).
As regard pain assessment in postoperative period, patients
in control group suffered from pain when measured by CHIP-
PS (0.93 ± 0.56) more than patients in dexmedetomidine
group (0.48 ± 0.45) and fentanyl group (0.13 ± 0.35)
(p< 0.05). The number of patients who suffered from pain
or discomfort was higher in dexmedetomidine group when
compared to fentanyl group (p< 0.05) (Fig. 2).
Regarding behavior during emergence, there were signiﬁ-
cant differences between the placebo with 40% agitation and
both fentanyl group with 21.4% agitation (p= 0.002) and
dexmedetomidine group with 16.7% agitation (p= 0.001),while there were no signiﬁcant differences between fentanyl
and dexmedetomidine groups (p> 0.05). For purposes of
analysis, grades 1 and 2 in the scale of behavior were consid-
ered no agitation and grades 3 and 4 were considered presence
of agitation (Table 6).
4. Discussion
The results of the current study showed that 40% of pediatric
patients developed emergence agitation after sevoﬂurane anes-
thesia. As all patients in this study were healthy, no oxygen
desaturation occurred, and ﬂuid and pain therapy were ade-
quate, so we can exclude hypoxia, pain and metabolic distur-
bance as causes of the agitation. In our study which had
been applied to children between 5 and 10 years old, using fen-
tanyl 1 lg/kg or dexmedetomidine 0.15 lg/kg after induction
of anesthesia with sevoﬂurane showed reduced incidence of
emergence agitation (21.4% and 16.7%, respectively) if com-
pared with placebo (40%), but the incidence of agitation was
slightly higher with fentanyl (21.4%) compared with dexmede-
tomidine (16.7%).
Emergence agitation is a common side effect of sevoﬂurane
in pediatric anesthesia, yet there is no clinical evidence that agi-
tation affects long term outcome. As mechanism of agitation
after sevoﬂurane anesthesia is not clear, there is no well-known
prophylaxis or treatment, although the incidence of this excit-
atory behavior seems to be reduced by the perioperative use of
sedative and analgesic drugs [9].
Similar to our ﬁndings, Cravero et al. [6] demonstrated that
addition of fentanyl 1 lg/kg to inhaled sevoﬂurane anesthesia
decreased incidence of postoperative agitation in children
scheduled for magnetic resonance imaging scans without any
surgical intervention. The ﬁrst study to describe postoperative
agitation done by Eckenhoff et al. [10] found that patients who
received an opioid-based anesthesia has less frequent incidence
of postoperative disturbance behavior when compared with
those who received cyclopropane anesthesia (0.4% vs. 8%).
With respect to the use of opioids and their effect on agitation,
Galinkin et al. [11] observed that the use of intranasal fentanyl
2 lg/kg administered after induction of anesthesia reduced the
incidence of agitation after sevoﬂurane anesthesia from 23%
to 2% without increasing the discharge times. In contrary to
our study, Aono et al. [12] stated that agitation after
sevoﬂurane anesthesia in children is present even if adequate
analgesia given intraoperatively or even if regional block was
used.
In the study by Lapin et al. [9] he compared placebo with
oral midazolam 0.5 mg/kg administered before surgery and
36 O.M. Asaad et al.found that midazolam reduced the incidence of agitation
after sevoﬂurane anesthesia from 67% to 39% after myrin-
gotomy surgery. While in another study, Viitanen et al.
[13] investigated children 1–3 years of age undergoing ade-
noidectomy and found that midazolam did not signiﬁcantly
inﬂuence the incidence of agitation but delayed recovery
from anesthesia. Davis et al. [14] observed that incidence
of excitement and agitation was less in patients receiving hal-
othane or sevoﬂurane when ketorolac was given IV after
induction of anesthesia (14% vs. 38%) (p< 0.05). Also
Johannesson et al. [15] found that acetaminophen given after
induction of anesthesia decreased agitation after sevoﬂurane
anesthesia. Murray et al. [16] evaluated the effect of
0.1 mg/kg oxycodone (premedication) on emergence in chil-
dren undergoing otolaryngology surgery using halothane or
sevoﬂurane anesthesia. Emergence agitation was decreased
in patients who received halothane anesthesia and oxycodone
premedication (15% vs. 45%) but not for patients receiving
sevoﬂurane.
In our study, Time to discharge from postanesthesia care
unit (PACU) was not affected with administration of fentanyl
and dexmedetomidine and the differences between them and
the placebo group were not signiﬁcant. Similar ﬁndings were
observed in the study of Joseph et al. [6] which documented
that time to reach discharge criteria was unchanged by the
addition of small dose of fentanyl to an anesthetic using sevo-
ﬂurane when compared with placebo.
Kulka et al. [17] documented a signiﬁcant decrease in agita-
tion (10% vs. 72%) in a clonidine-treated group undergoing
circumcision. Also, Bock et al. [18] have shown that clonidine
3 lg/kg intravenously or caudal is effective in preventing agita-
tion after sevoﬂurane anesthesia. In our study, we used dex-
medetomidine which is more speciﬁc than clonidine as a2
agonist. This was in agreement with the results of Ibacache
et al. [19] who observed that dexmedetomidine decreased the
incidence of agitation after sevoﬂurane anesthesia.
In our study, it was noticed that dexmedetomidine in a dose
of 0.15 lg/kg intravenously appear to be safe for intraoperative
use in children as regard hemodynamics. This ﬁnding are sup-
ported by amore recent work of Tobias et al. [20] who used dex-
medetomidine for controlled hypotensive anesthesia in children
with scoliosis for posterior spinal fusion by giving initial bolus
of dexmedetomidine 0.5 lg/kg then infusion dose of 0.25 lg/
kg/h. Kamibayashi andMaze [21] found that the sympatholytic
actions of dexmedetomidine resulted in reduction of blood pres-
sure and heart rate due to both sympatholytic as well as vago-
mimetic effect. However, Bloor et al. [22] found that
dexmedetomidine had competing vasodilator (central sympa-
tholytic a2-a) and vasoconstrictive (peripheral vascular a2-b) ef-
fects resulted in initial transient hypertension as a result of
initial high peak plasma levels of the drug. Following the rapid
redistribution of the loading dose, the centrally mediated sym-
patholytic effect of dexmedetomidine became dominant and
attenuation of sympathetic tone ensues. In our study, it was no-
ticed that with low dose of dexmedetomidine (0.15 lg/kg) there
was mild decrease in the MAP and HR intra-operatively but it
returned back to baseline values postoperatively.
Maxwell [23] was the ﬁrst to report the lack of respiratory
depression in patients receiving a2 agonists. However, more re-
cent data suggested that clonidine may cause mild respiratory
depression [24]. Ebert et al. [25] demonstrated that respiratory
rates increased with increased dexmedetomidine plasma con-centration in healthy volunteers. In another study comparing
dexmedetomidine to placebo in 33 patients, extubated after
major surgery, no difference in respiratory rates and arterial
oxygen saturation were found [26]. In addition, another study
data demonstrated that the slope of the CO2 response curve re-
mains unchanged in patients receiving dexmedetomidine [27].
In our study, it was found that administration of dexmedetom-
idine in a dose of 0.15 lg/kg over 10 min did not affect the
respiratory rate and end tidal CO2 as there were no signiﬁcant
differences between dexmedetomidine and placebo.
Manaa et al. [28] observed that the time for ﬁrst postoper-
ative analgesic dose was signiﬁcantly lower with dexmedetom-
idine when compared with placebo. Judith et al. [29] studied
the sedative, amnestic, and analgesic properties of small dose
dexmedetomidine infusion, in healthy volunteers, and discov-
ered that dexmedetomidine infusion resulted in reversible seda-
tion and mild analgesia due to its effect on the central a2
adrenoreceptors in the locus ceruleus and receptors in the dor-
sal horn of the spinal cord. In another study done by Ebert
et al. [25] on the effect of increasing plasma concentration of
dexmedetomidine in humans, they found that there is progres-
sive increase in sedation and analgesia with increasing concen-
tration of dexmedetomidine. In our study, it was noticed that
in postoperative period patients in control group suffered from
pain more than patients in the other two groups, and number
of patients who suffered from pain or discomfort were higher
in dexmedetomidine group compared to fentanyl group.
In conclusion, dexmedetomidine was found to be a safe
drug for use in spontaneously breathing pediatric patients un-
der general anesthesia and the incidence of postoperative agi-
tation in pediatric patients receiving sevoﬂurane was
decreased from 40% with placebo to 16.7% with intravenous
0.15 lg/kg dexmedetomidine and from 40% with placebo to
21.4% with intravenous 1 lg/kg fentanyl with no signiﬁcant
differences between dexmedetomidine group and fentanyl
group. However, further studies for the effects of different
doses of dexmedetomidine and fentanyl on emergence agita-
tion after sevoﬂurane anesthesia may be required.References
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